View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Mirvetuximab soravtansine 6, Ovarian Carcinoma
Protocol-ID: 2606 V1.0 (Mini), MIRSOR6, Ovarian CaIndication(s)
- Ovarian Tumor (Folate receptor alpha positive); ICD-10 C56
Links
- Prescribing information for mirvetuximab soravtansine (ELAHERE) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 30.05.2024